N. Areethamsirikul

The risk of secondary primary malignancies after therapy for multiple myeloma

D. Reece, N. Areethamsirikul, 2015, Leukemia & lymphoma.

Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia.

C. Hofmeister, S. Trudel, D. Reece, 2018, Blood.

Selinexor Demonstrates Marked Synergy with Dexamethasone (Sel-Dex) in Preclinical Models and in Patients with Heavily Pretreated Refractory Multiple Myeloma (MM)

A. Azmi, C. Hofmeister, D. Siegel, 2014 .

CyBorD induction therapy in clinical practice

S. Trudel, D. Reece, V. Kukreti, 2015, Bone Marrow Transplantation.

HLA‐haploidentical bone marrow transplantation for haematologic malignancies

S. Issaragrisil, E. Karoopongse, N. Areethamsirikul, 2013, Internal medicine journal.

Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia.

C. Hofmeister, S. Trudel, D. Reece, 2018, Blood.